Role of Karveeradi Tail in the management of Pama.

Phase 2

• Conditions: Health Condition 1: B998- Other infectious disease

• Registration Number: CTRI/2021/01/030705
• Lead Sponsor: Mahatma Gandhi Ayurved College Hospital and Research Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Diagnosed case of Pamakustha/Scabies with the symptoms Kandu, Toda, Daha,

Pidika, Strav

Exclusion Criteria

1. Patient suffering from any other systemic disorder such as skin tuberculosis, leprosy

etc.

2. Scabies with complication crust or hyperkeratosis and secondary infections.

3. Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Efficacy of Karveeradi Tail in PamaTimepoint: Efficacy of Karveeradi Tail in Pama in 21 days

Secondary Outcome Measures

Name	Time	Method
1. To study physio-chemical parameters of karveeraditail. 2. To study the efficacy of karveeradi tail in the management of Kandu, Toda ,Daha, Pidika <br/ ><br>and Strav. <br/ ><br>3. To compare the efficacy of karveeraditail with standard drug(Permethrin).Timepoint: Follow up will be on zero, 3rd, 7th, 14th, 21th